NCT/Study#

NCT03364231 /

TGR-1202-202

A Phase 2 Study to Assess the Efficacy and Safety of TGR-1202 (Umbralisib) Monotherapy in Patients with Non-Follicular Indolent Non-Hodgkin?s Lymphoma

A Phase 2 Study to Assess the Efficacy and Safety of TGR-1202 (Umbralisib) Monotherapy in Patients with Non-Follicular Indolent Non-Hodgkin?s Lymphoma

DISEASE GROUP:
Lymphoma
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: